PERSPECTA

News from every angle

← Back to headlines

Eli Lilly Terminates Licensing Agreement with Rigel for Ocadusertib

Pharmaceutical company Eli Lilly has ended its license agreement with Rigel Pharmaceuticals concerning the drug ocadusertib.

21 Apr, 21:36 — 21 Apr, 21:36
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed37d ago

Eli Lilly terminates license agreement with Rigel over ocadusertib

Read full article →

Related Stories

Extreme Training: What Heat Training Does to the Body

just now

Red Tide Warning Issued in Pangasinan, Philippines

just now

AstraZeneca's Imfinzi Approved for Additional Bladder Cancer Type

29m ago

Doctor Warns: Women's Body Changes Often Ignored

51m ago